PEBP1 and neoplasm: This process liberates Raf kinase inhibitory protein (RKIP), thereby inactivating the MAPK survival signaling pathway through RKIP-mediated phosphatase recruitment, which consequently potentiates lenvatinib-induced tumor cell apoptosis.